Mingyang An
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mingyang An has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Chunbao Li
2 shared publications- Feng Gao
Department of Sports Injury and Arthroscopy Surgery National Institute of Sports Medicine Beijing China
2 shared publications Yujie Liu
2 shared publicationsBaiqing Zhang
Department of Orthopedics Surgery, The Beijing Armed Police General Corps Hospital, Beijing, People’s Republic of China
1 shared publication- Baiqing Zhang
Beijing DCN Orthopedic Hospital Beijing China
1 shared publication - Baoxiang Zhang1 shared publication
Latest Publications
- Open Access
- 23 July 2026
- Published by Wiley in Orthopaedic Surgery
- Vol. 18 (9) , 1838-1846
Hip Arthroscopy During Female Menstruation: A Retrospective Analysis of Safety and Clinical Outcomes With 24‐Month Follow‐Up
Objectives: To investigate the safety and clinical outcomes of hip arthroscopy performed during menstruation in reproductive‐age female patients, and to determine whether surgery during menstruation increases intraoperative risks or adversely affects postoperative recovery. Currently, clear clinical guidelines regarding the timing of elective orthopedic surgeries relative to the menstrual cycle are lacking, often leading to unnecessary surgical rescheduling. Therefore, this study aimed to provide evidence‐based guidance for perioperative management and optimal surgical scheduling, thereby addressing a critical clinical need. Methods: This retrospective cohort study included reproductive‐age female patients who underwent hip arthroscopy at the First Medical Center of Chinese PLA General Hospital, the Fourth Medical Center of Chinese PLA General Hospital, and the Department of Sports Medicine at the Second Hospital of Shandong University from December 2018 to September 2023. Patients were categorized into the menstruation group (MP) and the non‐menstruation group (NMP) based on whether they were menstruating on the day of surgery. The NMP group consisted of equally sized ovulatory (OP) and luteal (LP) phases. Perioperative outcomes included: intraoperative blood loss, anesthetic dosage, operative time, hemoglobin (Hb) change (within 24 h postoperatively), prothrombin time (PT), and activated partial thromboplastin time (APTT). Postoperative outcomes included analgesic consumption, duration of analgesic use, time to first unassisted weight‐bearing ambulation, complications, and urinary tract infections. Functional outcomes were assessed at 24‐month follow‐up using the Visual Analog Scale (VAS), Modified Harris Hip Score (mHHS), International Hip Outcome Tool‐12 (iHOT‐12), Hip Outcome Score‐Activities of Daily Living (HOS‐ADL), and Hip Outcome Score‐Sports Specific Subscale (HOS‐SSS). Results: Of 884 eligible patients, 28 were included in the MP group and 56 matched patients in the NMP group. Operative time, anesthetic use, Hb change, PT, and APTT were comparable between the two groups (all p > 0.05). No serious complications or urinary tract infections occurred in either group. At the 24‐month follow‐up, both groups demonstrated significant improvements in VAS, mHHS, iHOT‐12, HOS‐ADL, and HOS‐SSS (all p < 0.001), with no statistically significant differences observed between the groups. Conclusions: Hip arthroscopy during menstruation does not increase intraoperative bleeding, impair coagulation, or delay functional recovery for female patients. Menstruation should not be considered a contraindication when appropriate perioperative management is applied.
- 23 July 2026
- Published by Wiley in Orthopaedic Surgery
- Vol. 18 (9) , 1838-1846
Open AccessHip Arthroscopy During Female Menstruation: A Retrospective Analysis of Safety and Clinical Outcomes With 24‐Month Follow‐Up
Objectives: To investigate the safety and clinical outcomes of hip arthroscopy performed during menstruation in reproductive‐age female patients, and to determine whether surgery during menstruation increases intraoperative risks or adversely affects postoperative recovery. Currently, clear clinical guidelines regarding the timing of elective orthopedic surgeries relative to the menstrual cycle are lacking, often leading to unnecessary surgical rescheduling. Therefore, this study aimed to provide evidence‐based guidance for perioperative management and optimal surgical scheduling, thereby addressing a critical clinical need. Methods: This retrospective cohort study included reproductive‐age female patients who underwent hip arthroscopy at the First Medical Center of Chinese PLA General Hospital, the Fourth Medical Center of Chinese PLA General Hospital, and the Department of Sports Medicine at the Second Hospital of Shandong University from December 2018 to September 2023. Patients were categorized into the menstruation group (MP) and the non‐menstruation group (NMP) based on whether they were menstruating on the day of surgery. The NMP group consisted of equally sized ovulatory (OP) and luteal (LP) phases. Perioperative outcomes included: intraoperative blood loss, anesthetic dosage, operative time, hemoglobin (Hb) change (within 24 h postoperatively), prothrombin time (PT), and activated partial thromboplastin time (APTT). Postoperative outcomes included analgesic consumption, duration of analgesic use, time to first unassisted weight‐bearing ambulation, complications, and urinary tract infections. Functional outcomes were assessed at 24‐month follow‐up using the Visual Analog Scale (VAS), Modified Harris Hip Score (mHHS), International Hip Outcome Tool‐12 (iHOT‐12), Hip Outcome Score‐Activities of Daily Living (HOS‐ADL), and Hip Outcome Score‐Sports Specific Subscale (HOS‐SSS). Results: Of 884 eligible patients, 28 were included in the MP group and 56 matched patients in the NMP group. Operative time, anesthetic use, Hb change, PT, and APTT were comparable between the two groups (all p > 0.05). No serious complications or urinary tract infections occurred in either group. At the 24‐month follow‐up, both groups demonstrated significant improvements in VAS, mHHS, iHOT‐12, HOS‐ADL, and HOS‐SSS (all p < 0.001), with no statistically significant differences observed between the groups. Conclusions: Hip arthroscopy during menstruation does not increase intraoperative bleeding, impair coagulation, or delay functional recovery for female patients. Menstruation should not be considered a contraindication when appropriate perioperative management is applied.
- 15 December 2025
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 44 (1) , e70121
M2 Macrophage‐Derived TGF‐β1 Drives Tendon Fibrosis in Rodent Tendinopathy Models
Tendinopathy is a common degenerative tendon disorder, characterized by extracellular matrix disorganization and progressive fibrosis. While macrophages play a role in fibrosis in other tissues, their specific function in tendon fibrosis remains unclear. This study aims to investigate the involvement of M2‐polarized macrophages and their secretion of transforming growth factor‐β1 (TGF‐β1) in tendon fibrosis. A chronic Achilles tendinopathy rat model was established by combining repetitive acupuncture needle puncture with treadmill overuse. Immunofluorescence and molecular biology techniques were used to assess M2 macrophage infiltration, TGF‐β1 expression, and JNK pathway activation. Pharmacological intervention was performed using GW2580 (CSF‐1R antagonist), and genetic knockout experiments were conducted in a mouse model. Results showed that the model group exhibited disrupted collagen structure and fibrotic matrix deposition in the tendon, accompanied by significant accumulation of CD206⁺ M2 macrophages and elevated TGF‐β1 expression. Immunofluorescence co‐localization revealed that TGF‐β1 was primarily produced by CD206⁺ macrophages. Activation of the JNK signaling pathway was observed. GW2580 treatment significantly reduced M2 macrophage infiltration, suppressed TGF‐β1 levels, and improved histological fibrosis scores. Genetic deletion of Tgf‐β1 in myeloid cells also alleviated fibrotic changes. In conclusion, M2 macrophage‐derived TGF‐β1 plays a crucial role in tendon fibrosis by activating the JNK signaling pathway, suggesting its potential as a therapeutic target.
- 15 December 2025
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 44 (1) , e70121
M2 Macrophage‐Derived TGF‐β1 Drives Tendon Fibrosis in Rodent Tendinopathy Models
Tendinopathy is a common degenerative tendon disorder, characterized by extracellular matrix disorganization and progressive fibrosis. While macrophages play a role in fibrosis in other tissues, their specific function in tendon fibrosis remains unclear. This study aims to investigate the involvement of M2‐polarized macrophages and their secretion of transforming growth factor‐β1 (TGF‐β1) in tendon fibrosis. A chronic Achilles tendinopathy rat model was established by combining repetitive acupuncture needle puncture with treadmill overuse. Immunofluorescence and molecular biology techniques were used to assess M2 macrophage infiltration, TGF‐β1 expression, and JNK pathway activation. Pharmacological intervention was performed using GW2580 (CSF‐1R antagonist), and genetic knockout experiments were conducted in a mouse model. Results showed that the model group exhibited disrupted collagen structure and fibrotic matrix deposition in the tendon, accompanied by significant accumulation of CD206⁺ M2 macrophages and elevated TGF‐β1 expression. Immunofluorescence co‐localization revealed that TGF‐β1 was primarily produced by CD206⁺ macrophages. Activation of the JNK signaling pathway was observed. GW2580 treatment significantly reduced M2 macrophage infiltration, suppressed TGF‐β1 levels, and improved histological fibrosis scores. Genetic deletion of Tgf‐β1 in myeloid cells also alleviated fibrotic changes. In conclusion, M2 macrophage‐derived TGF‐β1 plays a crucial role in tendon fibrosis by activating the JNK signaling pathway, suggesting its potential as a therapeutic target.
- 29 April 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 490
Injectable biomimetic hybrid nanofibers for targeting cartilage in early osteoarthritis treatment
- 29 April 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 490
Injectable biomimetic hybrid nanofibers for targeting cartilage in early osteoarthritis treatment
- Open Access
- 1 January 2024
- Published by KEAI Publishing in Journal of Magnesium and Alloys
- Vol. 12 (1) , 384-393
Degradable magnesium alloy suture promotes fibrocartilaginous interface regeneration in a rat rotator cuff transosseous repair model
- 1 January 2024
- Published by KEAI Publishing in Journal of Magnesium and Alloys
- Vol. 12 (1) , 384-393
Open AccessDegradable magnesium alloy suture promotes fibrocartilaginous interface regeneration in a rat rotator cuff transosseous repair model
- Open Access
- 1 May 2020
- Published by SAGE Publications in Journal of Orthopaedic Surgery
- Vol. 28 (2)
Local anesthesia combined with intra-articular ropivacaine can provide satisfactory pain control in ankle arthroscopic surgery: A retrospective cohort study
Local anesthesia (LA) is widely used in knee arthroscopic surgery but not in ankle arthroscopy. To understand the effectiveness and safety of LA combined with ropivacaine in pain control for ankle arthroscopy. Retrospective cohort. We retrospectively collected data for patients who underwent ankle arthroscopy from April 2012 to April 2017. Patients were grouped by anesthesia method: LA, LA with ropivacaine (LA+R), spinal anesthesia (SA), and SA with ropivacaine (SA+R). Intra- and postoperative visual analog scale (VAS) scores, complications, doses of supplemental pain medication, hospitalization cost and duration, and satisfaction with pain control during hospitalization were analyzed. The study included 276 patients (LA: 93; LA+R: 124; SA: 31; SA+R: 28). The LA and LA+R groups had significantly higher intraoperative VAS scores (LA vs. SA, p = 0.001; LA vs. SA+R, p = 0.002; LA+R vs. SA, p = 0.00; LA+R vs. SA+R, p = 0.00), but fewer complications, than the SA and SA+R groups. The LA+R and SA+R groups had significantly better outcomes for postoperative pain control (LA vs. LA+R, p = 0.01; LA vs. SA+R, p = 0.01; SA vs. SA+R, p = 0.01; SA vs. LA+R, p = 0.03) and required less supplemental pain medication. Hospitalization cost was lower and duration shorter in the LA and LA+R groups than in the SA and SA+R groups. There was no significant difference in satisfaction among the four groups. This was a single-center retrospective and relatively short-term study. LA+R which could be safely applied in ankle arthroscopy provided satisfactory pain control, reduced postoperative pain intensity, fewer complications, shorter hospital stay, and good cost-effectiveness. It can be safely applied in ankle arthroscopy for the specific patients with ankle osteoarthritis.
- 1 May 2020
- Published by SAGE Publications in Journal of Orthopaedic Surgery
- Vol. 28 (2)
Open AccessLocal anesthesia combined with intra-articular ropivacaine can provide satisfactory pain control in ankle arthroscopic surgery: A retrospective cohort study
Local anesthesia (LA) is widely used in knee arthroscopic surgery but not in ankle arthroscopy. To understand the effectiveness and safety of LA combined with ropivacaine in pain control for ankle arthroscopy. Retrospective cohort. We retrospectively collected data for patients who underwent ankle arthroscopy from April 2012 to April 2017. Patients were grouped by anesthesia method: LA, LA with ropivacaine (LA+R), spinal anesthesia (SA), and SA with ropivacaine (SA+R). Intra- and postoperative visual analog scale (VAS) scores, complications, doses of supplemental pain medication, hospitalization cost and duration, and satisfaction with pain control during hospitalization were analyzed. The study included 276 patients (LA: 93; LA+R: 124; SA: 31; SA+R: 28). The LA and LA+R groups had significantly higher intraoperative VAS scores (LA vs. SA, p = 0.001; LA vs. SA+R, p = 0.002; LA+R vs. SA, p = 0.00; LA+R vs. SA+R, p = 0.00), but fewer complications, than the SA and SA+R groups. The LA+R and SA+R groups had significantly better outcomes for postoperative pain control (LA vs. LA+R, p = 0.01; LA vs. SA+R, p = 0.01; SA vs. SA+R, p = 0.01; SA vs. LA+R, p = 0.03) and required less supplemental pain medication. Hospitalization cost was lower and duration shorter in the LA and LA+R groups than in the SA and SA+R groups. There was no significant difference in satisfaction among the four groups. This was a single-center retrospective and relatively short-term study. LA+R which could be safely applied in ankle arthroscopy provided satisfactory pain control, reduced postoperative pain intensity, fewer complications, shorter hospital stay, and good cost-effectiveness. It can be safely applied in ankle arthroscopy for the specific patients with ankle osteoarthritis.